Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Mira Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 20 | 29 | +9 |
| Shares | 1.00M | 1.40M | +395.1K (+39.5%) |
| Value | $1.21M | $1.89M | +$682.3K (+56.4%) |
New holders (10)
Institutions that held Mira Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 109,769 | $149.3K | 0.00% |
| Renaissance Technologies LLC | 46,700 | $63.5K | 0.00% |
| AQR Capital Management LLC | 22,000 | $29.9K | 0.00% |
| Virtu Financial LLC | 12,196 | $17.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 7,000 | $9.52K | 0.00% |
| Citigroup Inc | 3,820 | $5.20K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,797 | $2.44K | 0.00% |
| EverSource Wealth Advisors, LLC | 365 | $496 | 0.00% |
| FMR LLC | 115 | $156 | 0.00% |
| Wells Fargo & Company | 23 | $31 | 0.00% |
Sold out (1)
Institutions that held Mira Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Fortitude Family Office, LLC | 773 | $935 |